ArticleJournal of cardiology cases2025
Mixed shock after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Impella in crisis management.
Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alcohol septal ablation (ASA) for hypertrophic obstructive cardiomyopathy (HOCM) can lead to complex hemodynamic challenges. This report describes a case of a 79-year-old woman who developed mixed cardiogenic and distributive shock following ASA. Cardiogenic shock occurred due to complete atrioventricular block with insufficient cardiac output despite temporary right ventricular pacing. Concurrently, distributive shock developed secondary to bacterial pneumonia and exacerbation of polymyositis-associated interstitial lung disease. Fluid resuscitation, antibiotics, vasopressors, and hydrocortisone were ineffective. Inotropes, intra-aortic balloon pump, and veno-arterial extracorporeal membrane oxygenation were contraindicated because of the risk of worsening left ventricular outflow tract obstruction. An Impella 2.5 (Abiomed Inc., Danvers, MA, USA) was deployed, achieving hemodynamic stabilization without worsening left ventricular outflow tract obstruction. The patient recovered successfully through comprehensive intensive care and was discharged. This case highlights the potential efficacy of Impella support in managing complex mixed shock states after ASA. It emphasizes the multiple challenges in HOCM management, including addressing hemodynamic complexities due to left ventricular outflow tract obstruction, managing ASA-related complications, and simultaneously treating concurrent distributive shock. This comprehensive approach is crucial for developing effective individualized management strategies for patients with HOCM when dealing with postprocedural complications. Learning objective: This case illustrates complex hemodynamic complications following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. It emphasizes the importance of recognizing and managing mixed cardiogenic and distributive shock when standard treatments fail. The case highlights the potential role of Impella (Abiomed Inc., Danvers, MA, USA) support in stabilizing hemodynamics without exacerbating left ventricular outflow tract obstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.